查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933371

全球移植诊断市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测（2026-2034）

Transplant Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 请询问到货日

价格

移植诊断市场的成长驱动因素

全球移植诊断市场在确保器官和干细胞移植成功方面发挥关键作用，它能够实现精准的供体-受体匹配和有效的移植后监测。 2025年，全球移植诊断市场价值为26.9亿美元，预计2026年将成长至28.2亿美元，到2034年将达到44.5亿美元，预测期内复合年增长率为5.89%。北美地区在2025年占市场主导地位，占全球市场占有率的58.43%，这得益于其先进的医疗基础设施和庞大的移植手术量。

移植诊断包括分子和免疫学检测，例如 HLA 分型、交叉配对、供体特异性抗体筛检和排斥反应监测。这些诊断对于最大限度地减少器官排斥反应、优化免疫抑制疗法以及改善长期移植效果至关重要。对精准医疗和分子诊断的投入不断增加，进一步推动了市场成长。

市场动态

市场驱动因素

器官移植手术数量的增加以及对相容性检测的需求

由于末期肾病、肝衰竭和心臟病等慢性疾病的增加，全球对器官移植的需求显着增长。这种成长直接推动了对先进移植诊断检测的需求，以确保供体和受体的相容性以及移植后的成功。

例如，根据英国肾臟护理协会2024年的报告，英国约有6250人在等待肾臟移植。 PCR、次世代定序（NGS）和生物标记检测等技术的应用，使得更早发现排斥反应和改善临床决策成为可能，从而进一步推动了市场成长。

市场限制因子

捐赠器官短缺

儘管技术不断进步，供体器官短缺仍然是一个主要限制因素。移植候选人的数量远远超过可用捐赠者器官的数量，导致移植手术数量下降，诊断检测的使用率也随之下降。

根据美国捐赠生命组织（Donate Life America）统计，美国每年约有5600人在等待器官移植的过程中死亡，这凸显了供需缺口对市场成长的间接限製作用。

市场机会

移植基础建设投资增加

对移植中心和医疗基础设施的投资增加带来了巨大的成长机会。各国政府和私营机构都在积极宣传器官捐献，并致力于扩大移植设施。

例如，维多利亚医院于2025年4月宣布在印度班加罗尔开设一家新的器官采集和移植中心。该投资金额将达110万美元，以满足未来对移植诊断的需求。

市场挑战

严格的监管和报销政策

严格的监管要求和有限的报销范围给市场扩张带来了挑战。移植诊断必须满足高安全性和高准确性标准，这导致审批流程漫长且研发成本高昂。此外，许多地区的部分报销制度限制了移植诊断的普及，尤其是在发展中国家。

市场趋势

转型为非侵入性监测

移植诊断市场的关键趋势是非侵入性诊断技术的日益普及。基于血液的生物标记检测和基于定序的检测方法减少了侵入性活检的需求，从而能够早期发现排斥反应，同时最大限度地降低患者风险。

2024年6月，Omixon的NanoTYPE HLA扩增试剂盒获得IVDR批准，这标誌着市场正向先进的微创检测解决方案发生重大转变。

细分市场分析

依类型划分

试剂和耗材细分市场在2026年占主导地位，市占率达67.33%，主要得益于移植诊断中试剂盒和试剂的持续使用。由于新兴经济体移植基础设施的扩张，设备细分市场预计将保持稳定成长。

依检测方法

移植后反覆进行的排斥反应监测，旨在确保移植器官的长期存活，占了最大的市场占有率（预计2026年将达到46.46%）。

依技术方法

由于其成本效益和广泛应用，PCR技术预计在2026年将占26.71%的市场占有率。 同时，由于其卓越的准确性和在个人化医疗中的重要作用，次世代定序 (NGS) 预计将实现最高的成长率。

依移植类型划分

受需要器官移植的慢性疾病高发生率的推动，实体器官移植领域预计将在 2026 年占市场主导地位，市场占有率高达 95.21%。

依最终使用者划分

由于医院和移植中心移植手术集中度高且拥有先进的诊断基础设施，因此它们占了最大的市场占有率。

区域展望

预计到 2025 年，北美地区的收入将达到 15.7 亿美元，这主要得益于强有力的政府举措、先进诊断技术的广泛应用以及庞大的移植患者群体。 由于强大的研究合作，预计欧洲将呈现稳定成长；而由于慢性病负担加重以及印度、中国和日本移植计画的扩张，预计亚太地区将实现最高的复合年增长率。由于医疗基础设施的改善，预计拉丁美洲和中东及非洲地区将实现温和成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要疾病流行情况、主要国家和地区（2025/2026 年）
  • 移植诊断技术进展
  • 新产品发布、主要参与者
  • 关键产业趋势－併购及合作关係

第五章 全球移植诊断市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 仪器
    • 试剂与耗材
    • 软体与服务
  • 市场分析、洞察与预测：依检测项目划分
    • HLA分型
    • 交叉侦测
    • 供体特异性抗体（DSA）筛检
    • 排斥反应监测
    • 感染与移植监测
  • 市场分析、洞察与预测：依技术划分
    • PCR
    • 次世代定序
    • Sanger测序
    • 流式细胞仪
    • 血清学检测检测
    • 其他
  • 市场分析、洞察与预测：依移植类型划分
    • 实体器官移植
      • 肾臟移植
      • 肝臟移植
      • 肺臟移植
    • 干细胞/骨髓移植
  • 市场分析、洞察与预测：依最终用户划分
    • 医院及移植中心
    • 研究机构和学术机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美移植诊断市场分析：洞察与预测 （2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲移植诊断市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章 亚太地区移植诊断市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳大利亚
    • 中国
    • 印度
    • 东南亚
    • 南亚韩国
    • 亚太其他地区

第九章：拉丁美洲移植诊断市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲移植诊断市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 南非
    • 海湾合作委员会
    • 中东和非洲其他地区

第十一章：竞争分析

  • 全球市占率分析（2025）
  • 公司型材
  • Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Thermo Fisher Scientific
  • Qiagen
  • Admera Health, LLC
  • Bio-Rad Laboratories Inc.
  • Bruker
  • Werfen
  • BD
  • Other Prominent Players
Product Code: FBI114084

Growth Factors of transplant diagnostics Market

The global transplant diagnostics market plays a crucial role in ensuring the success of organ and stem cell transplantation by enabling accurate donor-recipient matching and effective post-transplant monitoring. In 2025, the global transplant diagnostics market was valued at USD 2.69 billion and is projected to grow to USD 2.82 billion in 2026, reaching USD 4.45 billion by 2034, registering a CAGR of 5.89% during the forecast period. North America dominated the market in 2025, accounting for 58.43% of the global share, driven by advanced healthcare infrastructure and a high number of transplant procedures.

Transplant diagnostics include molecular and immunological tests such as HLA typing, crossmatch testing, donor-specific antibody screening, and rejection monitoring. These diagnostics are essential to minimize organ rejection, optimize immunosuppressive therapy, and improve long-term transplant outcomes. Rising investments in precision medicine and molecular diagnostics are further strengthening market growth.

Market Dynamics

Market Drivers

Rising Organ Transplant Procedures and Need for Compatibility Testing

The increasing prevalence of chronic diseases such as end-stage kidney disease, liver failure, and heart disorders has significantly increased the demand for organ transplants worldwide. This rise has directly increased the need for advanced transplant diagnostic tests to ensure donor-recipient compatibility and post-transplant success.

For instance, in 2024, Kidney Care U.K. reported that approximately 6,250 people were on the kidney transplant waiting list in the U.K. The adoption of technologies such as PCR, next-generation sequencing (NGS), and biomarker testing has enabled early detection of rejection and improved clinical decision-making, further driving market growth.

Market Restraints

Limited Availability of Donor Organs

Despite technological advancements, the limited availability of donor organs remains a major restraint. The number of transplant candidates significantly exceeds the number of available donor organs, resulting in fewer transplant procedures and reduced utilization of diagnostic tests.

According to Donate Life America, around 5,600 people in the U.S. die annually while waiting for an organ transplant, highlighting the gap between demand and supply, which indirectly restricts market growth.

Market Opportunities

Rising Investments in Transplant Infrastructure

Growing investments in transplant centers and healthcare infrastructure provide significant growth opportunities. Governments and private institutions are actively promoting organ donation awareness and expanding transplant facilities.

For example, in April 2025, Victoria Hospital announced the launch of a new organ retrieval and transplant center in Bengaluru, India, with an investment of USD 1.1 million, supporting future demand for transplant diagnostics.

Market Challenges

Stringent Regulatory and Reimbursement Policies

Strict regulatory requirements and limited reimbursement coverage pose challenges to market expansion. Transplant diagnostics must meet high safety and accuracy standards, leading to lengthy approval timelines and high development costs. Additionally, partial reimbursement in many regions limits adoption, especially in developing economies.

Market Trends

Shift Toward Non-Invasive Monitoring

A major trend in the transplant diagnostics market is the growing adoption of non-invasive diagnostic technologies. Blood-based biomarker tests and sequencing-based assays reduce the need for invasive biopsies and allow early detection of rejection with minimal patient risk.

In June 2024, Omixon received IVDR approval for its NanoTYPE HLA amplification kit, highlighting the shift toward advanced and less invasive testing solutions.

Segmentation Analysis

By Type

The reagents & consumables segment dominated the market with a 67.33% share in 2026, due to continuous usage of test kits and reagents in transplant diagnostics. The instruments segment is expected to grow steadily with rising transplant infrastructure in emerging economies.

By Testing

Rejection monitoring held the largest market share (46.46% in 2026) as these tests are performed repeatedly after transplantation to ensure long-term graft survival.

By Technology

PCR technology accounted for 26.71% of the market share in 2026, owing to its cost-effectiveness and widespread availability. Meanwhile, NGS is expected to register the highest growth rate due to its superior accuracy and role in personalized medicine.

By Transplant Type

The solid organ transplant segment dominated the market with a 95.21% share in 2026, driven by the high prevalence of chronic diseases requiring organ replacement.

By End-user

Hospitals and transplant centers held the largest market share due to the high concentration of transplant procedures and access to advanced diagnostic infrastructure.

Regional Outlook

In 2025, North America generated USD 1.57 billion in revenue, supported by strong government initiatives, advanced diagnostics adoption, and a large transplant patient base. Europe shows steady growth due to strong research collaborations, while Asia Pacific is projected to record the fastest CAGR, driven by rising chronic disease burden and expanding transplant programs in India, China, and Japan. Latin America and the Middle East & Africa are expected to witness moderate growth with improving healthcare infrastructure.

Competitive Landscape

The market is moderately consolidated, with key players such as Thermo Fisher Scientific, Illumina, Qiagen, and F. Hoffmann-La Roche Ltd. leading through technological innovation, strategic partnerships, and product launches. Other prominent players include Bio-Rad Laboratories, Werfen, BD, and Bruker, contributing to competitive expansion.

Conclusion

The global transplant diagnostics market is expected to witness sustained growth from USD 2.69 billion in 2025 to USD 4.45 billion by 2034, driven by rising organ transplant procedures, advancements in molecular diagnostics, and increasing investments in transplant infrastructure. While challenges such as donor organ shortages and regulatory complexities persist, the growing shift toward non-invasive monitoring and precision diagnostics is strengthening market potential. Overall, transplant diagnostics remain essential for improving transplant success rates and long-term patient outcomes, ensuring steady market expansion over the forecast period.

Segmentation By Type

  • Instruments
  • Reagents & Consumables
  • Software & Service

By Testing

  • HLA Typing
  • Crossmatch Testing
  • Donor-Specific Antibody (DSA) Screening
  • Rejection Monitoring
  • Infection & Graft Monitoring

By Technology

  • PCR
  • Next-Generation Sequencing
  • Sanger Sequencing
  • Flow Cytometry
  • Serological Assays
  • Others

By Transplant Type

  • Solid Organ Transplantation
    • Kidney
    • Liver
    • Lung
    • Others
    • Stem Cell / Bone Marrow Transplantation

By End-user

  • Hospitals & Transplant Centers
  • Research & Academic Institutions
  • Others

By Region

  • North America (By Type, Testing, Technology, Transplant Type, End-user, and Country)
    • U.S. (By Transplant Type)
    • Canada (By Transplant Type)
  • Europe (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • Germany (By Transplant Type)
    • U.K. (By Transplant Type)
    • France (By Transplant Type)
    • Spain (By Transplant Type)
    • Italy (By Transplant Type)
    • Rest of Europe (By Transplant Type)
  • Asia Pacific (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • China (By Transplant Type)
    • Japan (By Transplant Type)
    • India (By Transplant Type)
    • Australia (By Transplant Type)
    • South Korea (By Transplant Type)
    • Rest of Asia Pacific (By Transplant Type)
  • Latin America (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • Brazil (By Transplant Type)
    • Mexico (By Transplant Type)
    • Rest of Latin America (By Transplant Type)
  • Middle East & Africa (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • GCC (By Transplant Type)
    • South Africa (By Transplant Type)
  • Rest of the Middle East & Africa (By Transplant Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2025
  • 4.2. Technological Advancements in Transplant Diagnostics
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Consumables
    • 5.1.3. Software & Service
  • 5.2. Market Analysis, Insights and Forecast - By Testing
    • 5.2.1. HLA Typing
    • 5.2.2. Crossmatch Testing
    • 5.2.3. Donor-Specific Antibody (DSA) Screening
    • 5.2.4. Rejection Monitoring
    • 5.2.5. Infection & Graft Monitoring
  • 5.3. Market Analysis, Insights and Forecast - By Technology
    • 5.3.1. PCR
    • 5.3.2. Next-Generation Sequencing
    • 5.3.3. Sanger Sequencing
    • 5.3.4. Flow Cytometry
    • 5.3.5. Serological Assays
    • 5.3.6. Others
  • 5.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 5.4.1. Solid Organ Transplantation
      • 5.4.1.1. Kidney
      • 5.4.1.2. Liver
      • 5.4.1.3. Lung
      • 5.4.1.4. Others
    • 5.4.2. Stem Cell / Bone Marrow Transplantation
  • 5.5. Market Analysis, Insights and Forecast - By End-User
    • 5.5.1. Hospitals & Transplant Centers
    • 5.5.2. Research & Academic Institutions
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East and Africa

6. North America Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Consumables
    • 6.1.3. Software & Service
  • 6.2. Market Analysis, Insights and Forecast - By Testing
    • 6.2.1. HLA Typing
    • 6.2.2. Crossmatch Testing
    • 6.2.3. Donor-Specific Antibody (DSA) Screening
    • 6.2.4. Rejection Monitoring
    • 6.2.5. Infection & Graft Monitoring
  • 6.3. Market Analysis, Insights and Forecast - By Technology
    • 6.3.1. PCR
    • 6.3.2. Next-Generation Sequencing
    • 6.3.3. Sanger Sequencing
    • 6.3.4. Flow Cytometry
    • 6.3.5. Serological Assays
    • 6.3.6. Others
  • 6.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 6.4.1. Solid Organ Transplantation
      • 6.4.1.1. Kidney
      • 6.4.1.2. Liver
      • 6.4.1.3. Lung
      • 6.4.1.4. Others
    • 6.4.2. Stem Cell / Bone Marrow Transplantation
  • 6.5. Market Analysis, Insights and Forecast - By End-User
    • 6.5.1. Hospitals & Transplant Centers
    • 6.5.2. Research & Academic Institutions
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
      • 6.6.1.1. By Transplant Type
    • 6.6.2. Canada
      • 6.6.2.1. By Transplant Type

7. Europe Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Software & Service
  • 7.2. Market Analysis, Insights and Forecast - By Testing
    • 7.2.1. HLA Typing
    • 7.2.2. Crossmatch Testing
    • 7.2.3. Donor-Specific Antibody (DSA) Screening
    • 7.2.4. Rejection Monitoring
    • 7.2.5. Infection & Graft Monitoring
  • 7.3. Market Analysis, Insights and Forecast - By Technology
    • 7.3.1. PCR
    • 7.3.2. Next-Generation Sequencing
    • 7.3.3. Sanger Sequencing
    • 7.3.4. Flow Cytometry
    • 7.3.5. Serological Assays
    • 7.3.6. Others
  • 7.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 7.4.1. Solid Organ Transplantation
      • 7.4.1.1. Kidney
      • 7.4.1.2. Liver
      • 7.4.1.3. Lung
      • 7.4.1.4. Others
    • 7.4.2. Stem Cell / Bone Marrow Transplantation
  • 7.5. Market Analysis, Insights and Forecast - By End-User
    • 7.5.1. Hospitals & Transplant Centers
    • 7.5.2. Research & Academic Institutions
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
      • 7.6.1.1. By Transplant Type
    • 7.6.2. Germany
      • 7.6.2.1. By Transplant Type
    • 7.6.3. France
      • 7.6.3.1. By Transplant Type
    • 7.6.4. Spain
      • 7.6.4.1. By Transplant Type
    • 7.6.5. Italy
      • 7.6.5.1. By Transplant Type
    • 7.6.6. Rest of Europe
      • 7.6.6.1. By Transplant Type

8. Asia Pacific Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Consumables
    • 8.1.3. Software & Service
  • 8.2. Market Analysis, Insights and Forecast - By Testing
    • 8.2.1. HLA Typing
    • 8.2.2. Crossmatch Testing
    • 8.2.3. Donor-Specific Antibody (DSA) Screening
    • 8.2.4. Rejection Monitoring
    • 8.2.5. Infection & Graft Monitoring
  • 8.3. Market Analysis, Insights and Forecast - By Technology
    • 8.3.1. PCR
    • 8.3.2. Next-Generation Sequencing
    • 8.3.3. Sanger Sequencing
    • 8.3.4. Flow Cytometry
    • 8.3.5. Serological Assays
    • 8.3.6. Others
  • 8.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 8.4.1. Solid Organ Transplantation
      • 8.4.1.1. Kidney
      • 8.4.1.2. Liver
      • 8.4.1.3. Lung
      • 8.4.1.4. Others
    • 8.4.2. Stem Cell / Bone Marrow Transplantation
  • 8.5. Market Analysis, Insights and Forecast - By End-User
    • 8.5.1. Hospitals & Transplant Centers
    • 8.5.2. Research & Academic Institutions
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
      • 8.6.1.1. By Transplant Type
    • 8.6.2. Australia
      • 8.6.2.1. By Transplant Type
    • 8.6.3. China
      • 8.6.3.1. By Transplant Type
    • 8.6.4. India
      • 8.6.4.1. By Transplant Type
    • 8.6.5. Southeast Asia
      • 8.6.5.1. By Transplant Type
    • 8.6.6. South Korea
      • 8.6.6.1. By Transplant Type
    • 8.6.7. Rest of Asia Pacific
      • 8.6.7.1. By Transplant Type

9. Latin America Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Consumables
    • 9.1.3. Software & Service
  • 9.2. Market Analysis, Insights and Forecast - By Testing
    • 9.2.1. HLA Typing
    • 9.2.2. Crossmatch Testing
    • 9.2.3. Donor-Specific Antibody (DSA) Screening
    • 9.2.4. Rejection Monitoring
    • 9.2.5. Infection & Graft Monitoring
  • 9.3. Market Analysis, Insights and Forecast - By Technology
    • 9.3.1. PCR
    • 9.3.2. Next-Generation Sequencing
    • 9.3.3. Sanger Sequencing
    • 9.3.4. Flow Cytometry
    • 9.3.5. Serological Assays
    • 9.3.6. Others
  • 9.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 9.4.1. Solid Organ Transplantation
      • 9.4.1.1. Kidney
      • 9.4.1.2. Liver
      • 9.4.1.3. Lung
      • 9.4.1.4. Others
    • 9.4.2. Stem Cell / Bone Marrow Transplantation
  • 9.5. Market Analysis, Insights and Forecast - By End-User
    • 9.5.1. Hospitals & Transplant Centers
    • 9.5.2. Research & Academic Institutions
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
      • 9.6.1.1. By Transplant Type
    • 9.6.2. Mexico
      • 9.6.2.1. By Transplant Type
    • 9.6.3. Rest of Latin America
      • 9.6.3.1. By Transplant Type

10. Middle East and Africa Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Consumables
    • 10.1.3. Software & Service
  • 10.2. Market Analysis, Insights and Forecast - By Testing
    • 10.2.1. HLA Typing
    • 10.2.2. Crossmatch Testing
    • 10.2.3. Donor-Specific Antibody (DSA) Screening
    • 10.2.4. Rejection Monitoring
    • 10.2.5. Infection & Graft Monitoring
  • 10.3. Market Analysis, Insights and Forecast - By Technology
    • 10.3.1. PCR
    • 10.3.2. Next-Generation Sequencing
    • 10.3.3. Sanger Sequencing
    • 10.3.4. Flow Cytometry
    • 10.3.5. Serological Assays
    • 10.3.6. Others
  • 10.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 10.4.1. Solid Organ Transplantation
      • 10.4.1.1. Kidney
      • 10.4.1.2. Liver
      • 10.4.1.3. Lung
      • 10.4.1.4. Others
    • 10.4.2. Stem Cell / Bone Marrow Transplantation
  • 10.5. Market Analysis, Insights and Forecast - By End-User
    • 10.5.1. Hospitals & Transplant Centers
    • 10.5.2. Research & Academic Institutions
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
      • 10.6.1.1. By Transplant Type
    • 10.6.2. GCC
      • 10.6.2.1. By Transplant Type
    • 10.6.3. Rest of Middle East and Africa
      • 10.6.3.1. By Transplant Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Hoffmann-La Roche Ltd.
    • 11.2.2. Illumina Inc.
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Qiagen
    • 11.2.5. Admera Health, LLC
    • 11.2.6. Bio-Rad Laboratories Inc.
    • 11.2.7. Bruker
    • 11.2.8. Werfen
    • 11.2.9. BD
    • 11.2.10. Other Prominent Players

List of Tables

  • Table 1: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 2: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 3: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 4: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 5: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 6: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 7: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Region, 2021-2034
  • Table 8: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 9: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 10: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 11: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 12: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 13: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 14: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country, 2021-2034
  • Table 15: U.S. Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 16: Canada Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 17: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 18: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 19: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 20: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 21: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 22: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 23: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 24: UK Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 25: Germany Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 26: France Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 27: Italy Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 28: Spain Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 29: Scandinavia Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 30: Rest of Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 33: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 34: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 35: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 36: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 37: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 38: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 39: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 40: China Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 41: Japan Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 42: India Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 43: Australia Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 44: South Korea Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 45: Southeast Asia Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 46: Rest of Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 48: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 49: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 50: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 51: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 52: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 53: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 54: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 55: Brazil Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 56: Mexico Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 57: Rest of Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 62: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 63: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 64: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 65: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 66: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 67: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 68: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 69: South Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 70: GCC Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 71: Rest of Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034

List of Figures

  • Figure 1: Global Transplant Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Transplant Diagnostics Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Transplant Diagnostics Market Value Share (%), by Testing, 2025 & 2034
  • Figure 4: Global Transplant Diagnostics Market Value Share (%), by Technology, 2025 & 2034
  • Figure 5: Global Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025 & 2034
  • Figure 6: Global Transplant Diagnostics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global Transplant Diagnostics Market Value (USD billlion), by Region, 2025 & 2034
  • Figure 8: North America Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 9: North America Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 10: North America Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 11: North America Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 12: North America Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 13: North America Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 14: North America Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 15: North America Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 16: North America Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 17: North America Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 18: North America Transplant Diagnostics Market Value (USD billlion), By Country, 2025 & 2034
  • Figure 19: North America Transplant Diagnostics Market Value Share (%), By Country, 2025
  • Figure 20: Europe Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 21: Europe Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 22: Europe Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 23: Europe Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 24: Europe Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 25: Europe Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 26: Europe Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 27: Europe Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 28: Europe Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 29: Europe Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 32: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 33: Asia Pacific Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 34: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 35: Asia Pacific Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 36: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 37: Asia Pacific Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 38: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 39: Asia Pacific Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 40: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 44: Latin America Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 45: Latin America Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 46: Latin America Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 47: Latin America Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 48: Latin America Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 49: Latin America Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 50: Latin America Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 51: Latin America Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 52: Latin America Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 53: Latin America Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 56: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 57: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 58: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 59: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 60: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 61: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 62: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 63: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 64: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 65: Middle East and Africa Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East and Africa Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 68: Global Transplant Diagnostics Market Share (%), By Company, 2025